Literature DB >> 36187519

Localized gastric mesothelioma with nodal metastasis-an exceptionally rare entity.

Mufaddal Kazi1, Tejas Vispute1, Prarthna Shah2, Mukta Ramadwar2, Manish S Bhandare1, Shailesh V Shrikhande1, Vikram A Chaudhari1.   

Abstract

Localized mesothelioma is a rare disease with very few reports of presentation in visceral organs. We report a case of localized gastric mesothelioma with lymph node metastasis in a 32-year-old man without asbestos exposure. A failed attempt at resection was made before presentation at another center. He was given perioperative chemotherapy that was followed by a D2 radical subtotal gastrectomy and hyperthermic intraperitoneal chemotherapy. Histopathology showed epithelioid mesothelioma with nodal metastasis but without visceral peritoneal involvement. Cytoreductive surgery and regional chemotherapy are standard in diffuse mesothelioma. Management of localized mesothelioma is anecdotal; however aggressive surgery plays a central role with selective use of perioperative chemotherapy.
© The Author(s), under exclusive licence to Indian Association of Surgical Oncology 2022.

Entities:  

Keywords:  Gastric; HIPEC; Localized mesothelioma; Mesothelioma; Peritoneal mesothelioma

Year:  2022        PMID: 36187519      PMCID: PMC9515280          DOI: 10.1007/s13193-022-01497-8

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  9 in total

Review 1.  Clinical presentation, diagnosis, classification and management of peritoneal mesothelioma: a review.

Authors:  Alfonso García-Fadrique; Akash Mehta; Faheez Mohamed; Sanjeev Dayal; Tom Cecil; Brendan J Moran
Journal:  J Gastrointest Oncol       Date:  2017-10

2.  Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The RENAPE Study.

Authors:  Brice Malgras; Etienne Gayat; Olivier Aoun; Réa Lo Dico; Clarisse Eveno; Karine Pautrat; Jean-Baptiste Delhorme; Guillaume Passot; Frédéric Marchal; Olivia Sgarbura; Gwenael Ferron; Diane Goéré; Thierry Andre; Marc Pocard
Journal:  Ann Surg Oncol       Date:  2018-07-05       Impact factor: 5.344

3.  Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of Survival.

Authors:  Vivek Verma; Richard L Sleightholm; Chad G Rusthoven; Matthew Koshy; David J Sher; Surbhi Grover; Charles B Simone
Journal:  Ann Surg Oncol       Date:  2018-05-02       Impact factor: 5.344

Review 4.  Malignant peritoneal mesothelioma: a review.

Authors:  Glenn Broeckx; Patrick Pauwels
Journal:  Transl Lung Cancer Res       Date:  2018-10

5.  Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

Authors:  Nicholas J Vogelzang; James J Rusthoven; James Symanowski; Claude Denham; E Kaukel; Pierre Ruffie; Ulrich Gatzemeier; Michael Boyer; Salih Emri; Christian Manegold; Clet Niyikiza; Paolo Paoletti
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

6.  Epithelioid malignant mesothelioma presenting with features of gastric tumor in a child.

Authors:  Qihan You; Jing Zhao; Genming Shi; Jing Deng; Xiaodong Teng
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

7.  Lymph node metastases in diffuse malignant peritoneal mesothelioma.

Authors:  Dario Baratti; Shigeki Kusamura; Antonello Domenico Cabras; Barbara Laterza; Maria Rosaria Balestra; Marcello Deraco
Journal:  Ann Surg Oncol       Date:  2009-10-24       Impact factor: 5.344

8.  US mesothelioma patterns 1973-2002: indicators of change and insights into background rates.

Authors:  Mary Jane Teta; Pamela J Mink; Edmund Lau; Bonnielin K Sceurman; Edward D Foster
Journal:  Eur J Cancer Prev       Date:  2008-11       Impact factor: 2.497

9.  Malignant peritoneal mesothelioma with lymph node metastasis that originated in the transverse colon.

Authors:  Yusuke Takehara; Shungo Endo; Yuichi Mori; Kenta Nakahara; Daisuke Takayanagi; Shoji Shimada; Tomokatsu Omoto; Chiyo Maeda; Shumpei Mukai; Eiji Hidaka; Fumio Ishida; Jun-ichi Tanaka; Shin-ei Kudo
Journal:  World J Surg Oncol       Date:  2014-04-23       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.